Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

gastrointestinal · Mechanism Report

Can the Firmicutes-to-Bacteroidetes ratio hide abnormal bacterial abundance and intestinal inflammation?

A normal Firmicutes-to-Bacteroidetes ratio can mask abnormal absolute bacterial abundance, and it does not measure intestinal inflammation.

PlausibleSeptember 28, 202611 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

Firmicutes and Bacteroidetes can both be elevated while their ratio remains normal, so the ratio alone can obscure abnormal absolute bacterial abundance and does not measure intestinal inflammation.

laying out figure…
2 of 6 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says the ratio is a relative microbiome summary, so both phyla can be elevated while the ratio still looks normal. The mechanism framing emphasizes that proportional shifts do not reveal absolute bacterial load, and that inflammation requires separate assessment rather than this ratio alone.

Verified conclusion

The claim is largely correct: the Firmicutes:Bacteroidetes (F:B) ratio is a proportional microbiome summary, not a measure of absolute bacterial quantity or intestinal inflammatory activity.

Abundance and ratio interpretation

  • A normal F:B ratio can coexist with elevated Firmicutes if Bacteroidetes increases proportionally; the same is mechanistically plausible for Bacteroidetes. The ratio therefore cannot establish whether either phylum—or total bacterial biomass—is increased, decreased, or unchanged.
  • This limitation follows from compositional data: relative abundances must sum to a fixed total, so an apparent shift in one group can arise from change elsewhere in the community or from altered overall microbial load.
  • Quantitative profiling is required to assess absolute abundance, using measures such as qPCR, flow-cytometric cell counts, or spike-in standards. In quantitative fecal microbiome work, microbial load varied by up to tenfold even among healthy individuals, and incorporating load changed inferred ecological and disease-associated patterns.
  • “Normal” and “elevated” remain assay-dependent terms; a ratio result alone does not provide validated reference-based evidence of bacterial expansion.

Inflammation

  • The F:B ratio does not measure, exclude, or reliably monitor intestinal inflammation. Phylum-level associations with inflammatory bowel disease are inconsistent and are influenced by disease phenotype, treatment, sample site, sequencing method, and analytic approach.
  • There are no validated prospective thresholds or diagnostic-performance data linking an F:B ratio to fecal calprotectin, endoscopic activity, or histologic inflammation.
  • Fecal calprotectin is a sensitive noninvasive marker that tracks endoscopic activity, although it is not specific to IBD. Endoscopy with histology remains the reference assessment when mucosal or microscopic inflammation must be established.

Bottom line

  • A normal F:B ratio can mask abnormal absolute microbial abundance and should not be used to infer intestinal inflammatory status. It is an exploratory relative-abundance metric, not a stand-alone clinical test.

References

  1. Current Applications of Absolute Bacterial Quantification in ... — pmc.ncbi.nlm.nih.gov ↗
  2. Establishing microbial composition measurement standards with reference frames — nature.com ↗
  3. Commentary: How to Count Our Microbes? The Effect of Different Quantitative Microbiome Profiling Approaches — frontiersin.org ↗
  4. Achieving quantitative and accurate measurement of the human gut microbiome — biorxiv.org ↗
  5. Fecal microbial load is a major determinant of gut microbiome variation and a confounder for disease associations — cell.com ↗
  6. Quantitative microbiome profiling links gut community variation to microbial load - Nature — nature.com ↗
  7. Systematic Review: The Gut Microbiome and Its Potential Clinical ... — pmc.ncbi.nlm.nih.gov ↗
  8. Gut Microbiota Is a Potential Biomarker in Inflammatory Bowel Disease — frontiersin.org ↗
  9. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1 — academic.oup.com ↗
  10. Practical guidance on the use of faecal calprotectin - PMC — pmc.ncbi.nlm.nih.gov ↗
  11. Fecal Calprotectin for the Diagnosis and Management of ... - PMC — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible7 sourcesCan chronic gastrointestinal dysfunction contribute to micronutrient deficiency?→Unsupported7 sourcesDoes an optimal TMAO result rule out excess activity in the microbial-hepatic pathway or prove gut microbiome balance?→